{
    "eid": "2-s2.0-85071710905",
    "title": "Extending the stalk enhances immunogenicity of the influenza virus neuraminidase",
    "cover-date": "2019-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Microbiology",
            "@code": "2404",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Insect Science",
            "@code": "1109",
            "@abbrev": "AGRI"
        },
        {
            "@_fa": "true",
            "$": "Virology",
            "@code": "2406",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "Immunodominance",
        "Influenza virus",
        "Neuraminidase",
        "Vaccine"
    ],
    "authors": [
        "Felix Broecker",
        "Allen Zheng",
        "Nungruthai Suntronwong",
        "Weina Sun",
        "Mark J. Bailey",
        "Florian Krammer",
        "Peter Palesea"
    ],
    "citedby-count": 18,
    "ref-count": 64,
    "ref-list": [
        "Influenza",
        "Naction! how can neuraminidase-based immunity contribute to better influenza virus vaccines?",
        "Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines",
        "Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans",
        "Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults",
        "Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses",
        "Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines",
        "Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel",
        "The human antibody response to influenza a virus infection and vaccination",
        "Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans",
        "Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice",
        "Cross-reactive neuraminidase-inhibiting antibodies elicited by immunization with recombinant neuraminidase proteins of H5N1 and pandemic H1N1 influenza a viruses",
        "Broadened immunity against influenza by vaccination with computationally designed influenza virus n1 neuraminidase constructs",
        "Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies",
        "Association of serum antineuraminidase antibody with resistance to influenza in man",
        "Induction of partial immunity to influenza by a neuraminidase-specific vaccine",
        "Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza a wild-type virus",
        "Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A/H1N1 virus healthy human challenge model",
        "Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to neuraminidase",
        "Antibody to influenza virus neuraminidase: An independent correlate of protection",
        "Independent and disparate evolution on nature of influenza a virus hemagglutinin and neuraminidase glycoproteins",
        "Antigenic drift of the influenza A(H1N1)pdm09 virus neuraminidase results in reduced effectiveness of A/California/7/ 2009 (H1N1pdm09)-specific antibodies",
        "Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice",
        "Molecular basis for broad neuraminidase immunity: Conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses",
        "Biological and protective properties of immune sera directed to the influenza virus neuraminidase",
        "Heterosubtypic neuraminidase antibodies against different A(H1N1) strains are elicited after seasonal influenza vaccination",
        "The role of antineuraminidase antibody in immunity to influenza virus infection",
        "Purified influenza a virus n2 neuraminidase vaccine is immunogenic and non-toxic in humans",
        "Broadly protective murine monoclonal antibodies against influenza b virus target highly conserved neuraminidase epitopes",
        "Broad and protective influenza b virus neuraminidase antibodies in humans after vaccination and their clonal persistence as plasma cells",
        "Antigen-presenting b cells and helper t cells cooperatively mediate intravirionic antigenic competition between influenza a virus surface glycoproteins",
        "Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience",
        "Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition",
        "In the shadow of hemagglutinin: A growing interest in influenza viral neuraminidase and its role as a vaccine antigen",
        "Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection",
        "Supplementation of conventional influenza a vaccine with purified viral neuraminidase results in a balanced and broadened immune response",
        "An H10N8 influenza virus vaccine strain and mouse challenge model based on the human isolate A/Jiangxi-Donghu/346/13",
        "Immunogenicity and protection against influenza H7N3 in mice by modified vaccinia virus ankara vectors expressing influenza virus hemagglutinin or neuraminidase",
        "Advances in the development of influenza virus vaccines",
        "Emergence and genetic variation of neuraminidase stalk deletions in avian influenza viruses",
        "Biologic importance of neuraminidase stalk length in influenza a virus",
        "Alterations of the stalk of the influenza virus neuraminidase: Deletions and insertions",
        "Neuraminidase inhibition contributes to influenza a virus neutralization by antihemagglutinin stem antibodies",
        "Sequence of the neuraminidase gene of an avian influenza a virus (a/parrot/ulster/73, H7N1)",
        "Microsecond molecular dynamics simulations of influenza neuraminidase suggest a mechanism for the increased virulence of stalk-deletion mutants",
        "A method to assess fc-mediated effector functions induced by influenza hemagglutinin specific antibodies",
        "Immunodominance of antigenic site b in the hemagglutinin of the current H3N2 influenza virus in humans and mice",
        "Influenza virus pleiomorphy characterized by cryoelectron tomography",
        "Stability of neuraminidase in inactivated influenza vaccines",
        "Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo",
        "Broadly neutralizing anti-influenza antibodies require fc receptor engagement for in vivo protection",
        "Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection",
        "Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza a virus",
        "Clustal w and clustal X version 2.0",
        "The influenza b virus hemagglutinin head domain is less tolerant to transposon mutagenesis than that of the influenza a virus",
        "Broadly protective monoclonal antibodies against h3 influenza viruses following sequential immunization with different hemagglutinins",
        "A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates",
        "Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system",
        "Measuring influenza virus neuraminidase inhibition antibody titers by enzyme-linked lectin assay",
        "Analysis of anti-influenza virus neuraminidase antibodies in children, adults, and the elderly by ELISA and enzyme inhibition: Evidence for original antigenic sin",
        "Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza a viruses",
        "The structure and receptor binding properties of the 1918 influenza hemagglutinin",
        "Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition",
        "UCSF chimera\u2014a visualization system for exploratory research and analysis"
    ],
    "affiliation": [
        {
            "affiliation-city": "New York",
            "@id": "60012981",
            "affilname": "Icahn School of Medicine at Mount Sinai",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012981",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Fatima Amanat",
        "MSTP",
        "Shirin Strohmeier",
        "NIH",
        "NIAID",
        "Icahn School of Medicine"
    ]
}